Atlas Trials

A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects

Clinical trial NCT03199261 · COMPLETED

Trial details

NCT number
NCT03199261
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2016-12-23
Primary completion
2017-01-21
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.